Avalon GloboCare Corp. (AVCO:NASDAQ) Annual Reports & Investor Relations Material

Overview

Avalon GloboCare Corp. is a clinical-stage biotech company that specializes in immune effector cell therapy, exosome technology, and COVID-19 related diagnostics and therapeutics. Through its subsidiary structure, the company offers strategic advisory and outsourcing services to support clients in the healthcare and CellTech markets. With its unique integration of verticals, Avalon is establishing a leading role in the fields of cellular immunotherapy, exosome technology, and regenerative therapeutics. The company is listed on the NASDAQ and is committed to advancing innovative and transformative bio-developments.

Frequently Asked Questions

What is Avalon GloboCare Corp.'s ticker?

Avalon GloboCare Corp.'s ticker is AVCO

What exchange is Avalon GloboCare Corp. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Avalon GloboCare Corp.'s headquarters?

They are based in Freehold, New Jersey

How many employees does Avalon GloboCare Corp. have?

There are 1-10 employees working at Avalon GloboCare Corp.

What is Avalon GloboCare Corp.'s website?

It is http://www.avalon-globocare.com/

What type of sector is Avalon GloboCare Corp.?

Avalon GloboCare Corp. is in the Real Estate sector